To support the development, licensing, and initial manufacturing of a human vaccine for valley fever.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To support the development, licensing, and initial manufacturing of a human vaccine for valley fever., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Environment.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HFD972FF8BE7841F8A92D502E5A0B696F: 1. Short title This Act may be cited as the Valley Fever Awareness and Vaccine Development and Manufacturing Act of 2024.
- Section HFFFE3EF30F9B4791B3FDDEF670486947: 2. Valley fever vaccine national strategy The Secretary shall coordinate with the relevant agency heads to support the development, licensing, and initial...
- Section H77AF2E01B7124CCFB5F3E46C8A795DD2: 3. Guidance on development, manufacturing, and approval of valley fever vaccine The Director of the National Institutes of Health, the Commissioner of Food and...
- Section HDB8AB6810B5B497CBDB55D6679F062A5: 4. Vaccine development and manufacturing The Secretary, acting through the Vaccine Coordinator and in consultation with the relevant agency heads, shall carry...
- Section HAE9C2777AF26439C82E5CDCC20F8896A: 5. Authorization of appropriations There are authorized to be appropriated to the Secretary— $1,000,000 for fiscal year 2026 to carry out section 2(b);...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To support the development, licensing, and initial manufacturing of a human vaccine for valley fever., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Environment
Primary Purpose
This bill, To support the development, licensing, and initial manufacturing of a human vaccine for valley fever., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMr. Duarte (for himself, Mr. Stanton, Mr. Schweikert, Mr. Costa, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
a national nonprofit organization with chapters or other affiliated organizations in States throughout the United States that have— experience serving the population of individuals with valley fever
a national nonprofit organization with chapters or other affiliated organizations in States throughout the United States that have— experience serving the population of individuals with valley fever
the Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology